de Hora M - Search Results

1

The Risk of Fatty Acid Oxidation Disorders and Organic Acidemias in Children with Normal Newborn Screening.

Wilson C, Knoll D, de Hora M, Kyle C, Glamuzina E, Webster D. Wilson C, et al. Among authors: de hora m. JIMD Rep. 2017;35:53-58. doi: 10.1007/8904_2016_25. Epub 2016 Dec 8. JIMD Rep. 2017. PMID: 27928776 Free PMC article.

2

The natural history of elevated tetradecenoyl-L-carnitine detected by newborn screening in New Zealand: implications for very long chain acyl-CoA dehydrogenase deficiency screening and treatment.

Ryder B, Knoll D, Love DR, Shepherd P, Love JM, Reed PW, de Hora M, Webster D, Glamuzina E, Wilson C. Ryder B, et al. Among authors: de hora m. J Inherit Metab Dis. 2016 May;39(3):409-414. doi: 10.1007/s10545-015-9911-z. Epub 2016 Jan 7. J Inherit Metab Dis. 2016. PMID: 26743058

3

Evaluation of the revised New Zealand national newborn screening protocol for congenital hypothyroidism.

Heather NL, Hofman PL, de Hora M, Carll J, Derraik JG, Webster D. Heather NL, et al. Among authors: de hora m. Clin Endocrinol (Oxf). 2017 Mar;86(3):431-437. doi: 10.1111/cen.13250. Epub 2016 Oct 21. Clin Endocrinol (Oxf). 2017. PMID: 27696498

4

The decision to discontinue screening for carnitine uptake disorder in New Zealand.

Wilson C, Knoll D, de Hora M, Kyle C, Glamuzina E, Webster D. Wilson C, et al. Among authors: de hora m. J Inherit Metab Dis. 2019 Jan;42(1):86-92. doi: 10.1002/jimd.12030. J Inherit Metab Dis. 2019. PMID: 30740730 Review.

5

Measurement of 17-Hydroxyprogesterone by LCMSMS Improves Newborn Screening for CAH Due to 21-Hydroxylase Deficiency in New Zealand.

de Hora MR, Heather NL, Patel T, Bresnahan LG, Webster D, Hofman PL. de Hora MR, et al. Int J Neonatal Screen. 2020 Jan 28;6(1):6. doi: 10.3390/ijns6010006. eCollection 2020 Mar. Int J Neonatal Screen. 2020. PMID: 33073005 Free PMC article.

6

Implementing steroid profiling by liquid chromatography-tandem mass spectrometry improves newborn screening for congenital adrenal hyperplasia in New Zealand.

de Hora MR, Heather NL, Patel T, Bresnahan LG, Webster D, Hofman PL. de Hora MR, et al. Clin Endocrinol (Oxf). 2021 Jun;94(6):904-912. doi: 10.1111/cen.14422. Epub 2021 Jan 31. Clin Endocrinol (Oxf). 2021. PMID: 33471388

7

Birth Weight- or Gestational Age-adjusted Second-tier LCMSMS Cutoffs Improve Newborn Screening for CAH in New Zealand.

de Hora MR, Heather NL, Webster D, Albert BB, Hofman PL. de Hora MR, et al. J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3390-e3399. doi: 10.1210/clinem/dgab383. J Clin Endocrinol Metab. 2021. PMID: 34058748

8

Introduction of a Protocol for Structured Follow-Up and Texting of Inadequate and Borderline-Positive Newborn Metabolic Screening Results.

Heather N, Morgan L, Knoll D, Shore K, de Hora M, Webster D. Heather N, et al. Among authors: de hora m. Int J Neonatal Screen. 2022 May 3;8(2):30. doi: 10.3390/ijns8020030. Int J Neonatal Screen. 2022. PMID: 35645284 Free PMC article.

9

Introducing Newborn Screening for Severe Combined Immunodeficiency-The New Zealand Experience.

Heather N, de Hora M, Brothers S, Grainger P, Knoll D, Webster D. Heather N, et al. Among authors: de hora m. Int J Neonatal Screen. 2022 May 10;8(2):33. doi: 10.3390/ijns8020033. Int J Neonatal Screen. 2022. PMID: 35645287 Free PMC article.

10

Evaluation of a New Laboratory Protocol for Newborn Screening for Congenital Adrenal Hyperplasia in New Zealand.

de Hora MR, Heather NL, Webster DR, Albert BB, Hofman PL. de Hora MR, et al. Int J Neonatal Screen. 2022 Oct 21;8(4):56. doi: 10.3390/ijns8040056. Int J Neonatal Screen. 2022. PMID: 36278626 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters